Get the latest delivered to your inbox
Privacy Policy

Now Reading

Novo Nordisk Publishes 2014 Integrated Annual Report Emphasising Long-Term Thinking

Novo Nordisk Publishes 2014 Integrated Annual Report Emphasising Long-Term Thinking

Published 02-07-15

Issued by Novo Nordisk

Report Highlights

Novo Nordisk's 2014 Annual Report highlights the company’s progression towards long-term targets taking an integrated approach that accounts for financial, social and environmental performance.  The 2014 report explains Novo Nordisk’s commitment to prevent, treat and ultimately cure diabetes, including a look into the company’s new global initiative, Cities Changing Diabetes®, that addresses the link between urbanisation and diabetes. It is a partnership programme to identify and address the root cause of urban diabetes in major cities around the world. The ambition is to identify, share and develop solutions for healthier living – and prevent diabetes.

These are the highlights of the social and environmental performance in 2014:

Social

  • Reaching an estimated 24.4 million people with diabetes care products
  • Creating more than 3,000 new jobs in the company
  • Maintaining a high level of employee engagement and adherence to the Novo Nordisk Way

Environmental

  • Achieving the long-term target for reduction of CO2 emissions from energy consumption for production: 45% in absolute terms since 2004, despite more than 200% business growth
  • Continuing decrease in energy consumption; a decrease of 1% compared to 2013

The report also accounts for challenges. Water consumption increased by 10% compared to 2013, requiring continued focus on water stewardship. And the company’s diversity ambition to have representation of both genders and more than one nationality in all senior management teams by the end of 2014 was not achieved.

Novo Nordisk

Novo Nordisk

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy. We believe that a healthy economy, environment and society are fundamental to long-term value creation. This is why we manage our business in accordance with the Triple Bottom Line business principle and consider the financial, environmental and social impact of our business decisions. The strategic commitment to corporate sustainability has brought the company onto centre stage as a leading player in today's business environment, recognised for its integrated reporting, stakeholder engagement and consistently high sustainability performance.

Join today and get the latest delivered to your inbox